Fortrea
Westcott (Wes) Samuel has a robust background in clinical research and project management, currently serving as a Clinical Research Associate II at Fortrea. Previous roles include Clinical Research Associate at ICON plc, In-House CRA at PRA Health Sciences, and Assistant Clinical Project Manager and Project Support Specialist at Bioclinica. Additionally, Westcott founded and is the CEO of 1212 Marketing, offering freelance marketing consultancy services. Westcott holds a Bachelor's Degree in Communications with a Minor in Marketing from Dallas Baptist University, earned between 2012 and 2014.
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.